Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression

Value in Health

Volumn 18, Issue 5, 2015, Pages 597-604

  Nguyen, Kim Huong ^a   Gordon, Louisa G ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

antidepressant; cost effectiveness analysis; economic evaluation; Markov model; microsimulation; repetitive transcranial magnetic stimulation

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DRUG COST; HAMILTON DEPRESSION RATING SCALE; HEALTH CARE COST; HIDDEN MARKOV MODEL; HUMAN; MAINTENANCE THERAPY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESISTANT DEPRESSION; COMPARATIVE STUDY; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; COST CONTROL; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; ECONOMIC MODEL; ECONOMICS; MARKOV CHAIN; PSYCHOLOGY; TIME FACTOR; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; COMPUTER SIMULATION; COST SAVINGS; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DRUG COSTS; HUMANS; MARKOV CHAINS; MODELS, ECONOMIC; QUALITY-ADJUSTED LIFE YEARS; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84941418307     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2015.04.004     Document Type: Article

References (26)

1. J.P. Lepine, and M. Briley The increasing burden of depression Neuropsychiatr Dis Treat 7 2011 3 7
2. D.A. Mrazek, J.C. Hornberger, C.A. Altar, and et al. A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013 Psychiatr Serv 65 2014 977 987
3. J.F. Greden The burden of recurrent depression: causes, consequences, and future prospects J Clin Psychiatry 62 Suppl 22 2001 5 9
4. L.L. Carpenter, P.G. Janicak, S.T. Aaronson, and et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice Depress Anxiety 29 2012 587 596
5. Z.J. Daskalakis, A.J. Levinson, and P.B. Fitzgerald Repetitive transcranial magnetic stimulation for major depressive disorder: a review Can J Psychiatry 53 2008 555 566
6. P.G. Janicak, Z. Nahas, S.H. Lisanby, and et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study Brain Stimul 3 2010 187 199
7. C.A. Wall, P.E. Croarkin, S.M. McClintock, and et al. Neurocognitive effects of repetitive transcranial magnetic stimulation in adolescents with major depressive disorder Front Psychiatry 4 2013 165
8. P. Fitzgerald Repetitive transcranial magnetic stimulation and electroconvulsive therapy: complementary or competitive therapeutic options in depression? Australas Psychiatry 12 2004 234 238
9. K.N. Simpson, M.J. Welch, F.A. Kozel, and et al. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis Adv Ther 26 2009 346 368
10. M. Knapp, R. Romeo, A. Mogg, and et al. Cost-effectiveness of transcranial magnetic stimulation vs. electroconvulsive therapy for severe depression: a multi-centre randomised controlled trial J Affect Disord 109 2008 273 285
11. F.A. Kozel, M.S. George, and K.N. Simpson Decision analysis of the cost-effectiveness of repetitive transcranial magnetic stimulation versus electroconvulsive therapy for treatment of nonpsychotic severe depression CNS Spectr 9 2004 476 482
12. C.P. Stephenson, E. Karanges, and I.S. McGregor Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011 Aust N Z J Psychiatry 47 2013 74 87
13. M.T. Berlim, F. Van den Eynde, and Z.J. Daskalakis Efficacy and acceptability of high frequency repetitive transcranial magnetic stimulation (rTMS) versus electroconvulsive therapy (ECT) for major depression: a systematic review and meta-analysis of randomized trials Depress Anxiety 30 2013 614 623
14. M.T. Berlim, F. Van den Eynde, and Z. Jeff Daskalakis Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials Neuropsychopharmacology 38 2013 543 551
15. M.T. Berlim, F. van den Eynde, S. Tovar-Perdomo, and et al. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials Psychol Med 44 2014 225 239
16. J. Ren, H. Li, L. Palaniyappan, and et al. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a systematic review and meta-analysis Prog Neuropsychopharmacol Biol Psychiatry 51 2014 181 189
17. A.J. Rush STAR∗D: what have we learned? Am J Psychiatry 164 2007 201 204
18. M. Sinyor, A. Schaffer, and A. Levitt The sequenced treatment alternatives to relieve depression (STAR∗D) trial: a review Can J Psychiatry 55 2010 126 135
19. A. Mantovani, M. Pavlicova, D. Avery, and et al. Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression Depress Anxiety 29 2012 883 890
20. H.A. Sackeim, R.F. Haskett, B.H. Mulsant, and et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial JAMA 285 2001 1299 1307
21. J.P. O'Reardon, H.B. Solvason, P.G. Janicak, and et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial Biol Psychiatry 62 2007 1208 1216
22. P.W. Sullivan, R. Valuck, J. Saseen, and et al. A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions CNS Drugs 18 2004 911 932
23. G. Hawthorne, F. Cheok, R. Goldney, and et al. The excess cost of depression in South Australia: a population-based study Aust N Z J Psychiatry 37 2003 362 373
24. P.G. Janicak, D.L. Dunner, S.T. Aaronson, and et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice CNS Spectr 18 2013 322 332
25. P.G. Janicak, J.P. O'Reardon, S.M. Sampson, and et al. Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment J Clin Psychiatry 69 2008 222 232
26. M.S. George, S.H. Lisanby, D. Avery, and et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial Arch Gen Psychiatry 67 2010 507 516